Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Moderate to Severe Psoriasis in Older Adults: Recommendations on Management from the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV).
Mataix J, García L, Belinchón I, Ruiz Carrascosa JC, de la Cueva P, Carrascosa JM. Mataix J, et al. Among authors: belinchon i. Actas Dermosifiliogr. 2023 Oct;114(9):802-811. doi: 10.1016/j.ad.2023.05.016. Epub 2023 May 25. Actas Dermosifiliogr. 2023. PMID: 37244396 Free article. English, Spanish.
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT).
Paul C, Puig L, Kragballe K, Luger T, Lambert J, Chimenti S, Girolomoni G, Nicolas JF, Rizova E, Lavie F, Mistry S, Bergmans P, Barker J, Reich K; TRANSIT Investigators. Paul C, et al. Br J Dermatol. 2014 Feb;170(2):425-34. doi: 10.1111/bjd.12646. Br J Dermatol. 2014. PMID: 24116959 Free article. Clinical Trial.
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis.
Reich K, Puig L, Paul C, Kragballe K, Luger T, Lambert J, Chimenti S, Girolomoni G, Nicolas JF, Rizova E, Brunori M, Mistry S, Bergmans P, Barker J; TRANSIT Investigators. Reich K, et al. Br J Dermatol. 2014 Feb;170(2):435-44. doi: 10.1111/bjd.12643. Br J Dermatol. 2014. PMID: 24116868 Clinical Trial.
Linear drug eruption.
Alfonso R, Belinchon I. Alfonso R, et al. Among authors: belinchon i. Eur J Dermatol. 2001 Mar-Apr;11(2):122-3. Eur J Dermatol. 2001. PMID: 11275808
Digital angioleiomyoma.
Albares MP, Belinchón I, Vergara G, Pascual JC, Pastor E. Albares MP, et al. Among authors: belinchon i. Int J Dermatol. 2002 Aug;41(8):527. doi: 10.1046/j.1365-4362.2002.15573.x. Int J Dermatol. 2002. PMID: 12207777 No abstract available.
Porokeratosis of the lower lip.
Vergara G, Bañuls J, Botella R, Silvestre JF, Belinchón I, Betlloch I. Vergara G, et al. Among authors: belinchon i. Eur J Dermatol. 2002 Sep-Oct;12(5):500-2. Eur J Dermatol. 2002. PMID: 12370146
Linear sebaceous gland hyperplasia of the penis: a case report.
Vergara G, Belinchón I, Silvestre JF, Albares MP, Pascual JC. Vergara G, et al. Among authors: belinchon i. J Am Acad Dermatol. 2003 Jan;48(1):149-50. doi: 10.1067/mjd.2003.28. J Am Acad Dermatol. 2003. PMID: 12522388 No abstract available.
Subungal abcesses secondary to paclitaxel.
Albares MP, Belinchón I, Pascual JC, Vergara G, Blanes M, Betlloch I. Albares MP, et al. Among authors: belinchon i. Dermatol Online J. 2003 Aug;9(3):16. Dermatol Online J. 2003. PMID: 12952763 Free article.
143 results